Financials

Company Profile

Scorpius Holdings, Inc. is not engaged in any business activities. The Company was previously a contract development and manufacturing organization.

Employees

Sector

Date	Price	Change	Volume
26-10-14	US$0.000100	-50.00%	15,466
26-10-12	US$0.000200	-.--%	1,437

Real-time OTC Markets

Market Closed - OTC Markets 10:29:25 2026-06-03 EDT			5-day change	1st Jan Change
0.001400 ^USD	+7.69%		+600.00%	+600.00%

04-24	Scorpius Holdings, Inc. Announces Board and Committee Changes	CI
04-08	Scorpius Holdings, Inc. Announces Resignation of William Ostrander as Chief Financial Officer, Effective March 31, 2026	CI

04-24	Scorpius Holdings, Inc. Announces Board and Committee Changes	CI
04-08	Scorpius Holdings, Inc. Announces Resignation of William Ostrander as Chief Financial Officer, Effective March 31, 2026	CI
03-10	Scorpius Holdings, Inc. announced that it has received $0.031175 million in funding	CI
02-25	Scorpius Holdings, Inc. announced that it has received $0.219544 million in funding	CI
02-17	Scorpius Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
02-11	Scorpius Holdings, Inc. announced that it has received $0.030427 million in funding	CI
01-12	Scorpius Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
12-15	Scorpius Holdings, Inc. announced that it has received $0.044374 million in funding	CI
12-10	Velocity Bioworks, Inc. acquired All of Personal Property and Assets of Scorpius Holdings, Inc. for $16.3 million.	CI
12-02	Scorpius Holdings, Inc. Announces Issuance of Multiple Non-Convertible Promissory Notes with Customary Terms	CI
11-30	Scorpius Holdings, Inc. announced that it has received $0.1541 million in funding	CI
11-25	Scorpius Holdings, Inc. announced that it has received $0.724523 million in funding	CI
11-24	Scorpius Holdings, Inc. announced that it has received $0.03795 million in funding	CI

23-05-01	Brookline Capital Downgrades NightHawk Biosciences to Hold From Buy	MT
23-04-03	Maxim Downgrades NightHawk Biosciences to Hold From Buy	MT
22-03-18	B. Riley Lowers Heat Biologics' PT to $8 from $10, Adjusts Model for Higher Cost of Capital to Support Higher Operating Expenditures Ramp; Keeps Buy Rating	MT
22-03-15	Alliance Global Adjusts Heat Biologics' Price Target to $15.50 From $20, Reiterates Buy Rating	MT
22-01-24	B. Riley Lowers Heat Biologics' Price Target to $10 from $15 After Revising Cost Capital Assumptions, Keeps Buy Rating	MT

01-12	Scorpius : Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)	PU
24-11-14	Scorpius : Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability Form 8 K	PU
24-10-22	Scorpius Holdings Announces Partnership with U.S. Biotech Company	AQ
24-10-02	Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats	AQ
24-09-30	Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities	AQ

Manager	Title	Age	Since
Jeff Wolf CEO	Chief Executive Officer	63	2010-03-31
Joe Payne COO	Chief Operating Officer	-	-
David Waldman IRC	Investor Relations Contact	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
5/16/24	Jeff Wolf	Free	Chief Executive Officer	5,000,000	13.8766%
5/16/24	Seed-One Ventures LLC	Other	Company	0	0%	-
5/16/24	Orion Holdings LLC	Other	Company	0	0%	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCORPIUS HOLDINGS, INC.	+7.69%	+600.00%	-87.27%	-100.00%	6.11K
INVESTOR AB	-1.47%	+0.72%	+31.04%	+95.77%	130B
INDUSTRIVÄRDEN AB	-1.25%	+1.19%	+30.82%	+79.10%	22.54B
HAL TRUST	-0.98%	0.00%	+19.26%	+50.19%	16.64B
MERITZ FINANCIAL GROUP INC.	-0.69%	+1.96%	+16.10%	+147.24%	15.66B
LUNDBERG B	-0.53%	+0.18%	+12.03%	+26.25%	14.3B
INVESTMENT AB LATOUR	-0.60%	+0.78%	-11.91%	+10.26%	13.39B
KINGDOM HOLDING COMPANY	-2.67%	-4.85%	+68.37%	+87.86%	13.33B
BAJAJ HOLDINGS & INVESTMENT LIMITED	+1.50%	+4.08%	-10.97%	+63.81%	12.98B
WASHINGTON H. SOUL PATTINSON AND COMPANY LIMITED	+0.11%	+1.90%	+22.52%	+34.11%	12.2B
Average	+0.12%	+0.91%	+9.00%	+49.46%	25.07B
Weighted average by Cap.	-1.10%	+1.67%	+25.32%	+80.85%